tiprankstipranks
BioAtla announces FDA clearance of IND for BA3361
PremiumThe FlyBioAtla announces FDA clearance of IND for BA3361
2M ago
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
2M ago
BioAtla price target lowered to $7 from $10 at H.C. Wainwright
PremiumThe Fly
BioAtla price target lowered to $7 from $10 at H.C. Wainwright
3M ago
Is BCAB a Buy, Before Earnings?
PremiumPre-EarningsIs BCAB a Buy, Before Earnings?
4M ago
BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PremiumPress Releases
BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
4M ago
BioAtla Rewards Executives for Meeting Performance Goals
PremiumCompany Announcements
BioAtla Rewards Executives for Meeting Performance Goals
4M ago
BioAtla to hold a virtual research and development day
PremiumThe FlyBioAtla to hold a virtual research and development day
7M ago
BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types
PremiumPress Releases
BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types
7M ago
BioAtla hosting R&D Day to highlight BA3071 CAB-CTLA-4 Phase 1 data
PremiumThe Fly
BioAtla hosting R&D Day to highlight BA3071 CAB-CTLA-4 Phase 1 data
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100